These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 26987810)

  • 1. The promise of protein glycosylation for personalised medicine.
    Almeida A; Kolarich D
    Biochim Biophys Acta; 2016 Aug; 1860(8):1583-95. PubMed ID: 26987810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycomics and glycoproteomics focused on aging and age-related diseases--Glycans as a potential biomarker for physiological alterations.
    Miura Y; Endo T
    Biochim Biophys Acta; 2016 Aug; 1860(8):1608-14. PubMed ID: 26801879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of disease: The human N-glycome.
    Lauc G; Pezer M; Rudan I; Campbell H
    Biochim Biophys Acta; 2016 Aug; 1860(8):1574-82. PubMed ID: 26500099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods for the absolute quantification of N-glycan biomarkers.
    Etxebarria J; Reichardt NC
    Biochim Biophys Acta; 2016 Aug; 1860(8):1676-87. PubMed ID: 26953846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short O-GalNAc glycans: regulation and role in tumor development and clinical perspectives.
    Chia J; Goh G; Bard F
    Biochim Biophys Acta; 2016 Aug; 1860(8):1623-39. PubMed ID: 26968459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UniCarbKB: New database features for integrating glycan structure abundance, compositional glycoproteomics data, and disease associations.
    Campbell MP; Packer NH
    Biochim Biophys Acta; 2016 Aug; 1860(8):1669-75. PubMed ID: 26940363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic defects in the hexosamine and sialic acid biosynthesis pathway.
    Willems AP; van Engelen BG; Lefeber DJ
    Biochim Biophys Acta; 2016 Aug; 1860(8):1640-54. PubMed ID: 26721333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycoblotting method allows for rapid and efficient glycome profiling of human Alzheimer's disease brain, serum and cerebrospinal fluid towards potential biomarker discovery.
    Gizaw ST; Ohashi T; Tanaka M; Hinou H; Nishimura S
    Biochim Biophys Acta; 2016 Aug; 1860(8):1716-27. PubMed ID: 26968461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case for protein-level and site-level specificity in glycoproteomic studies of disease.
    Schumacher KN; Dodds ED
    Glycoconj J; 2016 Jun; 33(3):377-85. PubMed ID: 27007620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enrichment of hydrophobic membrane proteins using Triton X-114 and subsequent analysis of their N-glycosylation.
    Pavić T; Gudelj I; Keser T; Pučić-Baković M; Gornik O
    Biochim Biophys Acta; 2016 Aug; 1860(8):1710-5. PubMed ID: 26746104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards personalized diagnostics via longitudinal study of the human plasma N-glycome.
    Hennig R; Cajic S; Borowiak M; Hoffmann M; Kottler R; Reichl U; Rapp E
    Biochim Biophys Acta; 2016 Aug; 1860(8):1728-38. PubMed ID: 27038647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unravelling Immunoglobulin G Fc N-Glycosylation: A Dynamic Marker Potentiating Predictive, Preventive and Personalised Medicine.
    Russell A; Adua E; Ugrina I; Laws S; Wang W
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29382131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Repertoire of Glycan Alterations and Glycoproteins in Human Cancers.
    Kori M; Aydin B; Gulfidan G; Beklen H; Kelesoglu N; Caliskan Iscan A; Turanli B; Erzik C; Karademir B; Arga KY
    OMICS; 2021 Mar; 25(3):139-168. PubMed ID: 33404348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG and IgM glycosylation patterns in patients undergoing image-guided tumor ablation.
    Breen LD; Pučić-Baković M; Vučković F; Reiding K; Trbojević-Akmačić I; Šrajer Gajdošik M; Cook MI; Lopez MJ; Wuhrer M; Camara LM; Andjelković U; Dupuy DE; Josić D
    Biochim Biophys Acta; 2016 Aug; 1860(8):1786-94. PubMed ID: 26827872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histo-blood group glycans in the context of personalized medicine.
    Dotz V; Wuhrer M
    Biochim Biophys Acta; 2016 Aug; 1860(8):1596-607. PubMed ID: 26748235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycans as cancer biomarkers.
    Adamczyk B; Tharmalingam T; Rudd PM
    Biochim Biophys Acta; 2012 Sep; 1820(9):1347-53. PubMed ID: 22178561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalised medicine in 2012: editorial to the special issue of New Biotechnology on "molecular diagnostics & personalised medicine".
    Desiere F; Romano Spica V
    N Biotechnol; 2012 Sep; 29(6):611-2. PubMed ID: 22504736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Personalised medicine in psychiatry and psychotherapy. A review of the current state-of-the-art in the biomarker-based early recognition of psychoses].
    Koutsouleris N; Ruhrmann S; Falkai P; Maier W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1522-30. PubMed ID: 24170081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-glycosylation-mutated HCV envelope glycoprotein complex enhances antigen-presenting activity and cellular and neutralizing antibody responses.
    Ren Y; Min YQ; Liu M; Chi L; Zhao P; Zhang XL
    Biochim Biophys Acta; 2016 Aug; 1860(8):1764-75. PubMed ID: 26278021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative glycosylation modulates function of IgG and other proteins - implications on evolution and disease.
    Gornik O; Pavić T; Lauc G
    Biochim Biophys Acta; 2012 Sep; 1820(9):1318-26. PubMed ID: 22183029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.